William Rees
3Patents
1h-index
16Co-inventors
37Inventor score
Filing activity: Nov 21, 2012 → Dec 16, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9914779B2 | Administration of alpha4beta7 hetero-dimer-specific antibody | Physics | 2 | Active |
| US11016099B2 | Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers | Emerging Cross-Sectional Technologies | 1 | Active |
| US11220541B2 | CCL20 as a predictor of clinical response to IL23-antagonists | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.